Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Congress
Business Wire
Learn More →
Scientific Publications
Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma
Frontiers in Oncology
Learn More →
Presentations
AI-driven Personalized Medicine for Cancer Care
Precision Medicine World Conference 2024
Learn More →
In the News
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
TechCrunch
Learn More →
Press Releases
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
Business Wire
Learn More →
Presentations
Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results
65th ASH Annual Meeting and Exposition
Learn More →
Presentations
Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions
Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen
Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Impact of AI on clinical practice and outcome
Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine
Veterinary Cancer Society Annual Conference 2023
Learn More →
In the News
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
USA Today
Learn More →
Scientific Publications
Prognostic value of European LeukemiaNet 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia
Haematologica
Learn More →
In the News
Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How
Innovative Veterinary Care Journal
Learn More →
In the News
How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue
Innovative Veterinary Care Journal
Learn More →
In the News
ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys
Innovative Veterinary Care Journal
Learn More →
In the News
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
International Business Times
Learn More →
Press Releases
ImpriMed Celebrates the Milestone of 4,000 Dog Blood Cancer Patients
Business Insider
Learn More →
In the News
New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships
Innovative Veterinary Care Journal
Learn More →
Previous
Next
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us
